Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMD Stem Cells
About this trial
This is a human clinical study making a noninvasive measurement from a patient's eye to determine whether there is a quantitative difference in measurements between patients with and without the diagnosis of dementia.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
All patients must be capable of an adequate ophthalmic evaluation and testing. This includes the ability to cooperate with the exam, sufficiently clear media (cornea, lens, vitreous) and sufficient pupillary dilation.
Patients must be capable of providing informed consent.
Patients who are not medically stable or who may be at significant risk to their health will not be eligible.
Women of child bearing age must not be pregnant at the time of examination.
Disqualifiers
None
Trial population
Diagnostic radiology practice
Trial design
Design model
Case-control
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
50 Participants
are grouped into 2 trial groupsGroup A: Patients diagnosed with dementia
Group B: Patients without cerebral pathology
Trial outcomes
Primary outcomes
1
Comparison of Dynamic Light Scattering Spectroscopy in Dementias
Dynamic light scattering will be compared between patients with dementias and patients with no cerebral pathology.
Time frame
Single measurement taken over 5 minutesSponsors and contacts
Click on the lead sponsor to view all of their trials.
MD Stem Cells
Lead sponsor
Jeffrey N Weiss MD
Collaborator
3T Radiology
Collaborator
The Healing Institute
Collaborator
Source ClinicalTrials.gov